Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1D2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,452
Award facts
- Contract value 100% obligated
- $16,452.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,452.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (quantity 30) on December 31, 2025, with an ultimate completion date of January 2, 2026. This non-competitive delivery order was placed without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Vraylar is a psychiatric medication used to treat conditions such as schizophrenia, bipolar disorder, and major depressive disorder, and this delivery supports federal medical supply needs, particularly for military and veteran healthcare systems.
This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 and running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent success in competing for federal medical supply requirements and delivering diverse pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA1D2?
SPE2DR26FA1D2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FA1D2 worth?
The government has obligated $16,452 on SPE2DR26FA1D2.
Is contract SPE2DR26FA1D2 an order under another contract?
Yes. SPE2DR26FA1D2 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1D2 competed?
The extent of competition for SPE2DR26FA1D2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award